I call this meeting to order.
Welcome to meeting 142 of the House of Commons Standing Committee on Health.
In accordance with our routine motion, I'm informing the committee that all remote participants have completed the required connection tests in advance of the meeting.
Pursuant to an order of reference adopted by the House of Commons on Wednesday, May 29, the committee is resuming its clause-by-clause consideration of Bill C-368, an act to amend the Food and Drugs Act in relation to natural health products.
I'd like to welcome our witnesses, who are available as experts for any questions related to the legislation that members may have. From the Department of Health, we have David Lee, chief regulatory officer of the health products and food branch; and Kim Godard, director general of the health product compliance directorate.
I recognize Mr. Naqvi and then Mr. Julian.